|
Insider Trading: LIGAND PHARMACEUTICALS INC
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of LIGAND PHARMACEUTICALS INC in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of LIGAND PHARMACEUTICALS INC since year 2005. Table 2 shows the detailed insider transactions of LIGAND PHARMACEUTICALS INC since 2005.
The reporting company's ticker symbol is LGND.
The reporting company's CIK number is 886163.
The total value of stock buying since 2005 is $8,390,237.
The total value of stock sales is $70,112,496.
The total value of stock exercises is $4,147,446.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at LIGAND PHARMACEUTICALS INC (LGND) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at LIGAND PHARMACEUTICALS INC (LGND) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for LIGAND PHARMACEUTICALS INC (LGND).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-05 | 515,300 | 1,749,335 | 512,300 | 1,739,258 | 0 | 0 |
| 2008-03 | 3,000 | 10,971 | 0 | 0 | 0 | 0 |
| 2007-11 | 2,000 | 8,560 | 0 | 0 | 0 | 0 |
| 2007-08 | 7,000 | 42,280 | 0 | 0 | 0 | 0 |
| 2007-06 | 402,100 | 2,748,083 | 400,100 | 2,734,683 | 0 | 0 |
| 2007-05 | 8,350 | 54,108 | 0 | 0 | 0 | 0 |
| 2007-04 | 0 | 0 | 0 | 0 | 10,005 | 42,392 |
| 2007-03 | 0 | 0 | 5,720,000 | 60,288,799 | 0 | 0 |
| 2006-12 | 350,000 | 3,776,900 | 217,783 | 2,383,387 | 217,783 | 1,707,277 |
| 2006-11 | 0 | 0 | 260,570 | 2,966,369 | 263,350 | 2,390,905 |
| 2006-03 | 0 | 0 | 0 | 0 | 1,841 | 6,872 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for LIGAND PHARMACEUTICALS INC (LGND)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-05-09 | Meglasson Martin (V-P, Discovery Research) | Purchase | 3,000 | 3.36 | 10,077 |
| 2008-05-09 | Knott David M (Director) | Purchase | 512,300 | 3.40 | 1,739,258 |
| 2008-05-09 | Knott David M (Director) | Sale | 512,300 | 3.40 | 1,739,258 |
| 2008-03-05 | Kozarich John W (Director) | Purchase | 3,000 | 3.66 | 10,971 |
| 2007-11-20 | Kozarich John W (Director) | Purchase | 2,000 | 4.28 | 8,560 |
| 2007-08-30 | Meglasson Martin (V-P, Discovery Research) | Purchase | 2,000 | 6.20 | 12,390 |
| 2007-08-29 | Kozarich John W (Director) | Purchase | 1,000 | 6.14 | 6,140 |
| 2007-08-13 | Kozarich John W (Director) | Purchase | 2,000 | 6.02 | 12,030 |
| 2007-08-13 | Higgins John L (President & CEO) | Purchase | 2,000 | 5.86 | 11,720 |
| 2007-06-15 | Higgins John L (President & CEO) | Purchase | 2,000 | 6.70 | 13,400 |
| 2007-06-15 | Knott David M (Director) | Purchase | 400,100 | 6.84 | 2,734,683 |
| 2007-06-15 | Knott David M (Director) | Sale | 400,100 | 6.84 | 2,734,683 |
| 2007-05-30 | Aryeh Jason (Director) | Purchase | 8,350 | 6.48 | 54,108 |
| 2007-04-02 | Blissenbach Henry F (Director) | Option Exercise | 10,005 | 4.24 | 42,392 |
| 2007-03-26 | Loeb Daniel S (Other) | Sale | 5,720,000 | 10.54 | 60,288,799 |
| 2006-12-15 | Meglasson Martin (V-P, Discovery Research) | Sale | 5,313 | 11.23 | 59,655 |
| 2006-12-15 | Meglasson Martin (V-P, Discovery Research) | Option Exercise | 5,313 | 7.25 | 38,519 |
| 2006-12-15 | Petttit William A (Sr. V-P, HR and Administration) | Sale | 30,000 | 11.28 | 338,520 |
| 2006-12-15 | Petttit William A (Sr. V-P, HR and Administration) | Option Exercise | 30,000 | 10.68 | 320,400 |
| 2006-12-15 | Groves Eric S (V-P, Project Management) | Sale | 50,000 | 11.23 | 561,500 |
| 2006-12-15 | Groves Eric S (V-P, Project Management) | Option Exercise | 50,000 | 7.62 | 381,250 |
| 2006-12-14 | Negro-vilar Andres (Exe V-P, R & D, CSO) | Sale | 6,666 | 11.19 | 74,585 |
| 2006-12-14 | Negro-vilar Andres (Exe V-P, R & D, CSO) | Option Exercise | 6,666 | 7.62 | 50,828 |
| 2006-12-13 | Loeb Daniel S (Director) | Purchase | 220,000 | 10.84 | 2,385,900 |
| 2006-12-13 | Negro-vilar Andres (Exe V-P, R & D, CSO) | Sale | 5,000 | 10.87 | 54,372 |
| 2006-12-13 | Negro-vilar Andres (Exe V-P, R & D, CSO) | Option Exercise | 5,000 | 7.62 | 38,125 |
| 2006-12-12 | Loeb Daniel S (Director) | Purchase | 130,000 | 10.70 | 1,391,000 |
| 2006-12-12 | Petttit William A (Sr. V-P, HR and Administration) | Sale | 45,804 | 10.60 | 485,598 |
| 2006-12-12 | Petttit William A (Sr. V-P, HR and Administration) | Option Exercise | 45,804 | 8.60 | 394,105 |
| 2006-12-11 | Negro-vilar Andres (Exe V-P, R & D, CSO) | Sale | 30,000 | 10.76 | 322,650 |
| 2006-12-11 | Negro-vilar Andres (Exe V-P, R & D, CSO) | Option Exercise | 30,000 | 7.38 | 221,250 |
| 2006-12-05 | Crouch Taylor (Sr. V-P, Ops & Pres. Int'l) | Sale | 45,000 | 10.81 | 486,507 |
| 2006-12-05 | Crouch Taylor (Sr. V-P, Ops & Pres. Int'l) | Option Exercise | 45,000 | 5.84 | 262,800 |
| 2006-11-20 | Maier Paul V (Sr. V-P, CFO) | Sale | 27,016 | 11.43 | 308,733 |
| 2006-11-20 | Maier Paul V (Sr. V-P, CFO) | Option Exercise | 27,016 | 9.25 | 249,898 |
| 2006-11-20 | Broaddus Warner R (V-P, Gen. Counsel & Secy.) | Sale | 3,646 | 11.48 | 41,856 |
| 2006-11-17 | Maier Paul V (Sr. V-P, CFO) | Sale | 77,190 | 11.37 | 877,836 |
| 2006-11-17 | Maier Paul V (Sr. V-P, CFO) | Option Exercise | 77,190 | 8.26 | 692,037 |
| 2006-11-17 | Broaddus Warner R (V-P, Gen. Counsel & Secy.) | Sale | 28,542 | 11.34 | 323,718 |
| 2006-11-17 | Broaddus Warner R (V-P, Gen. Counsel & Secy.) | Option Exercise | 28,542 | 8.25 | 235,471 |
| 2006-11-16 | Maier Paul V (Sr. V-P, CFO) | Sale | 54,772 | 11.37 | 622,971 |
| 2006-11-16 | Maier Paul V (Sr. V-P, CFO) | Option Exercise | 40,000 | 9.31 | 372,499 |
| 2006-03-01 | Cross Alexander D (Director) | Option Exercise | 1,841 | 3.73 | 6,872 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of LIGAND PHARMACEUTICALS INC (symbol LGND,
CIK number 886163) see
the Securities and Exchange Commission (SEC) website.
|
|
